Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's disease (AD) has been not only a substantial financial burden to the health care system ...
Alzheimer's disease (AD) is a highly prevalent condition and its prevalence is expected to further i...
OBJECTIVE: To conduct the first support vector machine (SVM)-based study comparing the diagnostic ac...
OBJECTIVES: This scoping study is the first step of a multiphase, international project aimed at des...
The use of Intelligent Assistive Technology (IAT) in dementia care opens the prospects of reducing t...
OBJECTIVE: Diabetic neuropathy is a chronic and often disabling condition that affects a significant...
BACKGROUND AND OBJECTIVES: A huge number of solutions based on computational systems have been recen...
BACKGROUND: Socially assistive robots are increasingly used as a therapeutic tool for people with de...
BACKGROUND AND OBJECTIVE: Alzheimers disease (AD) is a fatal neurodegenerative disease and the onset...
OBJECTIVES: To test the effects of individual, nonfacilitated sessions with PARO (version 9), when c...
Utilizing [18F]-AV-1451 tau positron emission tomography (PET) as an Alzheimer disease (AD) biomarke...
BACKGROUND: Predicting progression from a stage of Mild Cognitive Impairment to dementia is a major ...
BACKGROUND AND OBJECTIVE: The differentiation of mild cognitive impairment (MCI), which is the prodr...
Monitoring effects of disease or therapeutic intervention on brain function is increasingly importan...
OBJECTIVE: In many decision support systems, some input features can be marginal or irrelevant to th...
BACKGROUND: There are limited data on the use of artificial intelligence methods for the diagnosis o...
Identifying individuals destined to develop Alzheimer's dementia within time frames acceptable for c...
BACKGROUND: Dementia is a complex disorder characterized by poor outcomes for the patients and high ...
OBJECTIVES: To investigate the affective, social, behavioral, and physiological effects of the compa...
. Error-free diagnosis of Alzheimer's disease (AD) from healthy control (HC) patients at an early st...
Developing effective and affordable biomarkers for dementias is critical given the difficulty to ach...